These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9528170)

  • 1. [Formulation and stability of suspensions for preclinical study].
    Burgalassi S; Perini G; Giannaccini B; Saettone MF; Lodi A
    Boll Chim Farm; 1997 Nov; 136(10):628-34. PubMed ID: 9528170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of grewia gum as a suspending agent on ibuprofen pediatric formulation.
    Ogaji IJ; Hoag SW
    AAPS PharmSciTech; 2011 Jun; 12(2):507-13. PubMed ID: 21491182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development and stability studies of aqueous metronidazole benzoate suspensions containing various suspending agents.
    Zietsman S; Kilian G; Worthington M; Stubbs C
    Drug Dev Ind Pharm; 2007 Feb; 33(2):191-7. PubMed ID: 17454051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.
    Adeyeye CM; Price JC
    J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of suspending agent from sodium carboxymethyl mungbean starches.
    Kittipongpatana OS; Sirithunyalug J
    Drug Dev Ind Pharm; 2006 Aug; 32(7):809-20. PubMed ID: 16908418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a topical suspension containing three active ingredients.
    Chang HC; Li LC; Toongsuwan S; Stephens D; Liu RM; Plichta-Mahmoud H
    Drug Dev Ind Pharm; 2002 Jan; 28(1):29-39. PubMed ID: 11858522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A technical feasibility study of surfactant-free drug suspensions using octenyl succinate-modified starches.
    Kuentz M; Egloff P; Röthlisberger D
    Eur J Pharm Biopharm; 2006 May; 63(1):37-43. PubMed ID: 16356701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evaluation of shilajit as a suspending agent in antacid suspensions.
    Shahjahan M; Islam I
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1109-12. PubMed ID: 9876568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model suspensions of indomethacin "solvent deposited" on cellulose polymers.
    Bogdanova S
    Pharmazie; 2000 Nov; 55(11):829-32. PubMed ID: 11125999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
    Verma S; Gokhale R; Burgess DJ
    Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physical and chemical stability of suspensions of sustained-release diclofenac microspheres.
    Lewis L; Boni RL; Adeyeye CM
    J Microencapsul; 1998; 15(5):555-67. PubMed ID: 9743912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of suspending agents on the characteristics of some anti-inflammatory suspensions.
    Hashem F; Ramadan E; el-Said Y
    Pharmazie; 1987 Nov; 42(11):732-5. PubMed ID: 3438338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of
    Haile TG; Sibhat GG; Tadese E; Tesfay D; Molla F
    Biomed Res Int; 2020; 2020():7612126. PubMed ID: 33178834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral oil-based drospirenone microcrystal suspensions-evaluation of physicochemical stability and influence of stabilising agents.
    Nippe S; General S
    Int J Pharm; 2011 Sep; 416(1):181-8. PubMed ID: 21729745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of suspensions: theoretical and practical considerations before compounding.
    Hadžiabdić J; Elezović A; Rahić O; Mujezin I; Vranić E
    Int J Pharm Compd; 2015; 19(1):78-85. PubMed ID: 25902632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of physical stability and dissolution rate of celecoxib suspensions by complexation with beta-cyclodextrins.
    Chandra Sekhara Rao G; Satish Kumar M; Mathivanan N; Bhanoji Rao ME
    Pharmazie; 2004 Aug; 59(8):627-30. PubMed ID: 15378853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cissus stem gum as potential dispersant in pharmaceutical liquid systems 2: The emulsifying and suspending properties.
    Alfa J; Chukwu A; Udeala OK
    Boll Chim Farm; 2001; 140(2):68-75. PubMed ID: 11417389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
    Stanisz BJ; Paszun SK; Zalewska A
    Acta Pol Pharm; 2014; 71(4):661-6. PubMed ID: 25272892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of the dissolution rate of poorly soluble drugs by solid crystal suspensions.
    Thommes M; Ely DR; Carvajal MT; Pinal R
    Mol Pharm; 2011 Jun; 8(3):727-35. PubMed ID: 21344937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ophthalmic suspensions using surface tension.
    Yasueda S; Inada K; Matsuhisa K; Terayama H; Ohtori A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):377-82. PubMed ID: 15018999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.